2024
DOI: 10.1039/d3tb02624h
|View full text |Cite
|
Sign up to set email alerts
|

A promising ‘single’ and ‘dual’ drug-nanocomposite enriched contact lens for the management of glaucoma in response to the tear fluid enzyme

B. N. Kumara,
K. Velmurugan,
M. Vivek Ghate
et al.

Abstract: Glaucoma is a neurodegenerative condition that results in the damage of retinal ganglion cells due to elevated intraocular pressure (IOP). To curtail the limitations with conventional treatments such as eye...

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 60 publications
0
1
0
Order By: Relevance
“…Glaucoma patients can benefit from both the controlled application of medications to the eye and the accurate tracking of IOP through SCLs. Kumara et al (2024) developed a contact lens for glaucoma management that can deliver a single drug (latanoprost) or two drugs simultaneously (latanoprost and timolol) to the ocular surface [72]. Their design relies on a chitosan-based nanocomposite material which entraps the drug product and is hydrolyzed in the presence of naturally occurring lysozyme in tear.…”
Section: Glaucomamentioning
confidence: 99%
“…Glaucoma patients can benefit from both the controlled application of medications to the eye and the accurate tracking of IOP through SCLs. Kumara et al (2024) developed a contact lens for glaucoma management that can deliver a single drug (latanoprost) or two drugs simultaneously (latanoprost and timolol) to the ocular surface [72]. Their design relies on a chitosan-based nanocomposite material which entraps the drug product and is hydrolyzed in the presence of naturally occurring lysozyme in tear.…”
Section: Glaucomamentioning
confidence: 99%